Table 3:

Table of adverse events

	No TVS	TVS	p-value
All-cause mortality, N(%)	7 (25.0%)	4 (12.5%)	0.654
RVAD, N(%)	4 (14.3%)	3 (9.4%)	0.913
AV Block, N(%)	1 (3.6%)	0 (0.0%)	n.s.
Tricuspid prosthetic dysfunction, N(%)	0 (0%)	0 (0%)	n.s.
Endocarditis, N(%)	0 (0%)	0 (0%)	n.s.
Major bleeding, N(%)			0.799
No major bleeding	16 (57.1%)	16 (50.0%)
Early Post-op Bleeding	4 (14.3%)	9 (28.1%)
Late Post-op Bleeding	8 (28.6%)	7 (21.9%)
Stroke, N(%)	2 (7.1%)	3 (9.4%)	n.s.
Pump thrombosis, N(%)	0 (0%)	0 (0%)	n.s.
Prolonged mechanical ventilation (>72hrs), N(%)	4 (14.3%)	6 (18.8%)	n.s.
New dialysis requirement, N(%)	1 (3.6%)	1 (3.1%)	n.s.

^*n.s. = not significant